Kaplan-Meyer plot. This plot shows survival of patients with less than 5% BM blasts (WHO groups: RA, RCMD, RARS, RCMD/RS, and 5q-), treated with G-CSF plus Epo within the Nordic MDS Group trials. Unilineage dysplasia (uni; median survival, 67 months) versus multilineage dysplasia (multi; median survival, 28.5 months), P = .03, is shown.